Evidence map›Paper›PMID 29934732›Full record

ReviewUpdates in surgery2018

Resection line involvement after gastric cancer treatment: handle with care.

Paolo Morgagni, Giuliano La Barba, Eleonora Colciago, Giovanni Vittimberga, Giorgio Ercolani

Abstract readReview
PubMed Publisher
In one paragraph

Review in Updates in surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paolo MorgagniDepartment of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy. paolo.morgagni@auslromagna.it.
Giuliano La BarbaDepartment of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy.
Eleonora ColciagoDepartment of Surgery and Translational Medicine, Milano-Bicocca University, San Gerardo Hospital, Monza, Italy.
Giovanni VittimbergaDepartment of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy.
Giorgio ErcolaniDepartment of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy.
Ospedale G.B. Morgagni - L.Pierantoni · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal management of patients with resection line involvement after endoscopic or surgical treatment for gastric cancer is debated. In contrast to previous reports, we examined both the experience of endoscopists and surgeons in early-stage lesions and the wide variation in treatments proposed for advanced disease in case of infiltration of resection margins. A PubMed search for papers using the key words: gastric or stomach cancer, or Carcinoma; gastrectomy and positive margins; surgical margins or resection line or endoscopic margin involvement; and R1 resection, from January 2000 to July 2015 was undertaken. Fifty-three studies were considered pertinent to the study. Many endoscopists report that some cases of early gastric cancer with resection line involvement after endoscopic resection have good outcomes notwithstanding incomplete resection, but few surgeons share this opinion. Conversely, it is unanimously agreed that very advanced stages should not be surgically retreated because they are expression of systemic disease. Between early and very advanced cancer the usefulness of re-resection for microscopic resection lines involvement is still debated and surgery may be proposed only when radicality can be achieved. When surgery is not feasible, radiochemotherapy may represent a valid alternative.

Indexed as

Margins of ExcisionChemoradiotherapy, AdjuvantEndoscopy, GastrointestinalGastrectomyHumansLymph Node ExcisionNeoplasm StagingRecurrenceReoperationRisk FactorsStomach NeoplasmsEndoscopic submucosal dissectionFrozen sectionGastric cancerInfiltrated resection marginR1 resectionRadiochemotherapyResection line involvement

Identifiers

PMID29934732
OpenAlexW2811151067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.